• 한국염색가공학회지
• /
• 제22권3호
• /
• pp.229-238
• /
• 2010

Poly($\varepsilon$-caprolactone) nano/microcapsules(nmcPCL) containing phytoncide oil were synthesized by emulsion diffusion method using ethyl acetate and poly(vinyl alcohol) (PVA) as an organic solvent and an emulsion stabilizer respectively. The influence of the degree of saponofication of the PVA and the weight ratio of core to wall materials was investigated to design nanocapsules in terms of particle size, morphology, and emulsion stability. The encapsulated nmcPCL were characterized by FT-IR spectrometry, particle size analyzer and scanning electron microscope. Mean size of nanocapsules prepared with PVA with a degree of saponofication of 87% was smaller than those of PVA with a degree of saponofication of 98.5% and the mean particle size of the capsules decreased with increasing core/shell ratio.

• Journal of Pharmaceutical Investigation
• /
• 제31권4호
• /
• pp.257-263
• /
• 2001

The microspheres have been developed as a new drug delivery system. Although many particulate drug carriers, such as liposome, niosome and emulsion, have been introduced, injectable and biodegradable microspheres appears to be a particularly ideal delivery system because the local anesthesia is not necessary for the insertion of large implants and for the removal of the device after the drug release is finished. Biodegradable microspheres with nicotine and triamcinolone acetonide are prepared and evaluated. As biodegradible polymers, PLA (M.W. 15,000, PLA-0015), PLGA (M.W. 17,000, RG 502) and PLGA (M.W. 8,600, RG 502H) are used. This study attempted to prepare and evaluate the nicotine and triamcinolone acetonide-incorporated microspheres, which were prepared by two methods, solvent-evaporation and spray-drying methods. The microspheres, as a disperse system for injections, were evaluated by particle size, size distribution, entrapment efficiency, and in vitro drug release patterns. The differences of preparation method, partition coefficient, types of polymer, and preparation conditions of microspheres influence the particle size, entrapment efficiency, and in vitro drug release patterns.

• Journal of Pharmaceutical Investigation
• /
• 제30권1호
• /
• pp.47-50
• /
• 2000

A new technique has been developed for the preparation of Lactobacillus microcapsules to enhance the stability against high temperature, humidity, gastric acid and bile acid. Employing fluidized bed coating, primary sub-coating was processed in non-organic solvent system, so that Lactobacillus did not directly contact with organic solvent. Secondary enteric-coating was processed in organic solvent with low temperature $(below\;33^{\circ}C)$ technique, which minimized the heat labilability of Lactobacillus. Survival rate of Lactobacillus within microcapsule was not less than 95% and acid tolerance was above 30% in the artificial gastric acid. Further more it was dissolved in the artificial intestine juice within 2-3 hr. Average size of Lactobacillus microcapsules was $450\;{\mu}m$(25-50 mesh) and its viability was above 90% in the direct tableting.

• 한국염색가공학회지
• /
• 제28권3호
• /
• pp.164-174
• /
• 2016

In this study, dye-encapsulated microcapsules were produced by emulsion polymerization using styrene monomer. The study showed that the average size of microcapsules were $2{\sim}5{\mu}m$ in normal distribution. These microcapsules induced pale yellow(A12) and reddish yellow(B24) color by thermochromic fluoran yellow(dye A) and red(dye B). These microcapsules were changed to dark yellow(A12) and scarlet(B24) color depending on temperature change. The weight of microcapsules decreased by 7% to 11% during the heating ranges from $320^{\circ}C$ to $350^{\circ}C$ implying that the styrene microcapsules had thermal stability upto $300^{\circ}C$.

• 반도체디스플레이기술학회지
• /
• 제19권3호
• /
• pp.30-35
• /
• 2020

A microlens has been fabricated by various methods such as a thermal reflow, hot embossing, diamond milling, etc. However, these methods require a relatively complex process to control the microlens shape. In this work, we report on a simple and cost-effective method to fabricate a cylindrical microlens (CML), which can diffuse light widely. We have employed a slot-die head with the dual plate (a meniscus guide with a protruded μ-tip and a shim with a slit channel) for coating of a narrow stripe using poly(methyl methacrylate) (PMMA). We have shown that the higher the coating gap, the lower the maximum coating speed, which causes an increase in the stripe width and thickness. The coated PMMA stripe has the concave shape. To make it in the shape of a convex microlens, we have applied the thermal reflow method. When the stripe thickness is small, however, its effect is negligible. To increase the stripe thickness, we have increased the number of repeated coating. With this scheme, we have fabricated the CML with the width of 223 ㎛ and the thickness of 7.3 ㎛. Finally, we have demonstrated experimentally that the CML can diffuse light widely, a feature demanded for light extraction efficiency of organic light-emitting diodes (OLEDs) and suppression of moiré patterns in displays.

• 약학회지
• /
• 제41권1호
• /
• pp.30-37
• /
• 1997

In order to formulate a controlled release system for oral drug delivery, the microcapsules were prepared in w/o emulsion containing cefaclor as a water-soluble model drug by th e method of interfacial polycondensation. Gelatin wis selected as a suitable polymer for interfacial polycondensation. Gelatin solution containing drug was emulsified in an organic phase under mechanical stirring. After emulsification, terephthaloyl chloride was added as cross linking agent, followed by mechanical stirring, washing and drying. Physical characteristics of microcapsules were investigated by optical microscopy, scanning electron microscopy and particle size analysis. Mean particle sizes of gelatin microcapsules were, in the range, of about 20~50 ${\mu}$m. The microcapsules were in good apperance with spherical shapes before washing, but were destroyed partially after washing and drying, even though some microcapsules were still maintained in their shapes. Contents of cefaclor in the microcapsules were calculated by UV spectrophotometry after 3 days extraction with pH 4 carbonate buffer solution. The effects of cross linking time. pH. concentration of cross-linking agent, and temperature on drug release kinetics have been discussed extensively.

• 약학회지
• /
• 제41권5호
• /
• pp.607-614
• /
• 1997

Flurbiprofen- and flurbiprofen axetil-loaded microemulsions composed of soybean oil, poloxamer 407, glycerine and water were prepared by generator-type homgenizer and ultrasoni c probe system. The particle size of microemulsions was measured by the dynamic light scattering method. The pharmacokinetics and organ distribution of flurbiprofen were investigated after intravenous injection of flurbiprofen solution, flurbiprofen-loaded microemulsion and flurbiprofen axetil-loaded microemulsions equivalent to 10mg/kg of flurbiprofen to rats. Blood samples were collected from the anterior ciliary artery of rats for 24hr, and flurbiprofen in plasma and organs was analyzed by HPLC. Stable microemulsions were prepared. Even though there is a little change in droplet size just after the preparation, no creaming and no separation were occured during the storage period for 6 months at 4, 21, 37 and 45$^{\circ}C$. Pharmacokinetic parameters and organ distribution of flurbiprofen after intravenous injection of flurbiprofen- and flurbiprofen axetil-loaded microemulsions emulsified with poloxamer 407 were not significantly different from those of commercial lipid microemulsion emulsified with lecithin. Therefore, it is concluded that flurbiprofen- and flurbiprofen axetil-loaded microemulsion prepared with poloxamer 407 could be used as a parenteral formulation.

• 약학회지
• /
• 제45권6호
• /
• pp.623-633
• /
• 2001

Various bupivacaine-loaded microspheres were prepared using poly(d,1-lactide) (PLA) and poly(d,1-lactic-co-glycolide) (PLGA) by a solvent evaporation method for the sustained release of drug. The effects of process conditions such as drug loading, polymer type and solvent type on the characteristics of microspheres were investigated. The prepared microspheres were characterized for their drug loading, size distribution, surface morphology and release kinetics. Drug loading efficiency and yield of PLGA micro- spheres were higher than those of PLA microspheres. The prepared microspheres had an average particle size below 5${\mu}{\textrm}{m}$. The particle size range of microspheres was 1.65~2.24${\mu}{\textrm}{m}$. As a result of SEM, the particle size of PLA microspheres was smaller than that of PLGA microspheres. In morphology studies, microspheres showed a spherical shape and smooth surface in all process conditions. In thermal analysis, bupivacaine-loaded microspheres showed no peaks originating from bupivacaine. This suggested that bupivacaine base was molecular-dispersed in the polymer matrix of microspheres. The release pattern of the drug from microspheres was evaluated for 96 hours. The initial burst release of bupivacaine base decreased with increasing the molecular weight of PLGA, and the drug from microspheres released slowly. In conclusion, bupivacaine-loaded microspheres were successfully prepared from poly(d,1-lactide) and poly (d,1- lactic-co-glycolide) polymers with different molecular weights allowing control of the release rate.

• 약학회지
• /
• 제32권1호
• /
• pp.26-39
• /
• 1988

Eudragit $RS^{\circledR}$ polymer was used as a wall material for the microencapsulation of aspirin by a phase separation method from chloroform-cyclohexane system with 5% polyisobutylene (PIB) in cyclohexane, and microcapsules obtained were evaluated by particle size analysis, scanning electron microscopy (SEM), drug release and drug stability test. With PIB as a coacervation inducing agent, smooth and tight microcapsules with less aggregation were obtained. Below 1 : 0.3 core-wall ratio, it was possible to coat individual particle. Variation of production conditions showed that increasing the proportion of wall material, particle size and wall thickness of microcapsules and the concentration of paraffin wax in cyclohexane as a sealant sustained drug release rates effectively. SEM confirmed that larger microcapsules after drug release did not rupture into smaller particles but contained a few small pores on the surface. Aspirin release from Eudragit $RS^{\circledR}$ coated microcapsules was independent of the pH of medium, and the mechanism of drug release from non-sealed and sealed microcapsules appeared to fit Higuchi matrix model kinetics. Aspirin in the mixture of aspirin microcapsules and sodium bicarbonate was by far more stable than that in the mixture of pure aspirin and sodium bicarbonate.

• 전자통신동향분석
• /
• 제21권4호통권100호
• /
• pp.107-117
• /
• 2006

위성 탑재체 제조 산업은 기초 과학이 뒷받침된 초정밀 기계 공학, 첨단 전자 기술, 극한 환경 기술 및 신소재 공학 등과 같은 첨단 산업의 집합체라 할 수 있다. 현재 미국을 비롯한 서구 선진국에서 진행중인 탑재체 기술동향을 보면, 폭발적으로 증가하는 위성수에 따라 위성 궤도가 부족하고 주파수 자원이 고갈되고 있는 상황에서 통신 위성의 효율성과 성능을 향상시킬 수 있는 신호처리 탑재(OBP) 위성과 통신기능을 포함한 다양한 기능을 가진 복합위성 개발이 진행되고 있으며 주파수 대역의 포화와 광대역 멀티미디어 서비스 제공 등을 위해 보다 높은 주파수의 준 밀리미터파 대역(Ka 대역) 위성 개발이 활발히 이루어지고 있다. 국내에서는 현재, 2008년 발사를 목표로 마이크로스위치 매트릭스(MSM)가 탑재되어 빔간 스위칭이 가능하도록 설계된 통신해양기상위성(COMS)용 통신 탑재체(SACOM) 개발이 진행중이다. 국내의 위성탑재용 RF 부품분야는 1990년부터 위성 중계기 시스템의 기본적인 설계, 조립, 종합화, 시험기술을 바탕으로 통신위성 탑재체용 초고주파 부품을 개발하여 왔으며, 2000년대에는 Ku 대역(12/14GHz) 및 Ka 대역(20/30GHz) 기술인증모델(EQM) RF 부품을 성공적으로 개발하였다. 이를 바탕으로 통신해양기상위성 통신탑재체용 Ka 대역 RF 부품이 현재 우주인증 모델(QM)의 개발이 완료되었으며 비행 모델(FM) 개발이 진행중이다.